Effect of lisinopril on tissue levels of neuropeptide Y in normotensive and spontaneously hypertensive rats

Journal of Human Hypertension

Volumn 14, Issue 6, 2000, Pages 381-384

  Corder, Roger ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Angiotensin converting enzyme; Blood pressure; Lisinopril; Neuropeptide Y; Sympathetic nervous system

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; LISINOPRIL; NEUROPEPTIDE Y; NORADRENALIN;

ANIMAL EXPERIMENT; BLOOD PRESSURE; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME INHIBITION; HYPERTENSION; NERVOUS SYSTEM; NONHUMAN; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; SYMPATHETIC NERVE; TISSUE DISTRIBUTION; TISSUE LEVEL;

EID: 0033946062     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1001024     Document Type: Conference Paper

References (15)

1. Edwards CRW, Padfield PL. Angiotensin converting enzyme inhibitors: past, present and bright future. Lancet 1985; i: 30-34.
2. Cassis LA, Save J, Peach MJ. Location and regulation of rat angiotensinogen messenger RNA. Hypertension 1988; 11: 591-596.
3. Cockcroft JR, O'Kane KP, Webb DJ. Tissue angiotensin generation and regulation of vascular tone. Pharmacol Therap 1995; 65: 193-213.
4. Bristow MR, Abraham WT. Anti-adrenergic effects of angiotonsin converting enzyme inhibitors. Eur Heart J 1995; 16 (Suppl K): 37-41.
5. Moursi MG, Ganten D, Lang RE, Unger T. Antihypertensive action and inhibition of tissue converting enzyme (CE) by three prodrug CE inhibitors, enalapril, ramipril and perindopril in stroke-prone spontaneously hypertensive rats. J Hypertens 1986; 4: S495-S498.
6. Cody RJ. The sympathetic nervous system and the renin-angiotensin-aldosterone system in cardiovascular disease. Am J Cardiol 1997; 80: 9J-14J.
7. Ekhlad E et al. Neuropeptide Y co-exists and co-operates with noradrenaline in perivascular nerve fibres. Regul Pept 1984; 8: 225-235.
8. Lundberg JM, Rudehill A, Sollevi A, Hamberger B. Evidence for co-transmitter role of neuropeptide Y in the pig spleen. Br J Pharmacol 1989; 96: 675-687.
9. Hartmann JF et al. Effects of the angiotensin converting enzyme inhibitor, lisinopril, on normal and diabetic rats. J Hypertens 1988; 6: 677-683.
10. Corder R et al. Effect of ganglion blockade with pentolinium on circulating neuropeptide Y levels in conscious rats. J Cardiovasc Pharmacol 1988; 12: 140-143.
11. Corder R, Lowry PJ. An immunoradiometric assay for the measurement of neuropeptide Y in plasma. Peptides 1985; 6: 1195-1200.
12. Clough DP, Hatton R, Keddie JR, Collis MG. Hypotensive action of captopril in spontaneously hypertensive and normotensive rats: interference with neurogenic vasoconstriction. Hypertension 1982; 4; 764-772.
13. Zolk O et al. Effects of quinapril, losartan and hydralazine on cardiac hypertrophy and β-adrenergic neuroeffector mechanisms in transgenic (mREN2)27 rats. Br J/ Pharmacol 1998; 123: 405-412.
14. Moreau P, de Champlain J, Yamaguchi N. Alterations in circulating levels and cardiovascular tissue content of neuropeptide Y-like immunoreactivity during the development of deoxycorticosterone acetate-salt hypertension in the rat. J Hypertens 1992; 10: 773-780.
15. Corder R et al. Central and peripheral effects of repeated stress and high NaCl diet on neuropeptide Y. Physiol Behav 1992; 52: 205-210.